Cargando…
Treatment Preferences in Patients With Early Glottic Cancer
OBJECTIVE: For early glottic carcinoma, the 2 main treatment modalities are radiotherapy (RT) and transoral CO(2) laser microsurgery (TLM). The aim of this study was to investigate treatment preferences and considerations in patients with early glottic carcinoma (T1-T2) who were given a choice betwe...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815424/ https://www.ncbi.nlm.nih.gov/pubmed/29291278 http://dx.doi.org/10.1177/0003489417749253 |
_version_ | 1783300497067737088 |
---|---|
author | van Loon, Yda Hendriksma, Martine Langeveld, Ton P.M. de Jong, Martin A. Baatenburg de Jong, Rob J. Sjögren, Elisabeth V. |
author_facet | van Loon, Yda Hendriksma, Martine Langeveld, Ton P.M. de Jong, Martin A. Baatenburg de Jong, Rob J. Sjögren, Elisabeth V. |
author_sort | van Loon, Yda |
collection | PubMed |
description | OBJECTIVE: For early glottic carcinoma, the 2 main treatment modalities are radiotherapy (RT) and transoral CO(2) laser microsurgery (TLM). The aim of this study was to investigate treatment preferences and considerations in patients with early glottic carcinoma (T1-T2) who were given a choice between TLM and RT. SUBJECTS AND METHODS: Patients with early glottic cancer (suspected or confirmed extended T1 or limited T2) were counseled by an ENT-surgeon. A subset of 32 patients was also counseled by a radiotherapist. Treatment choice and considerations were recorded and analyzed. RESULTS: Of 175 patients, 168 patients (96%) chose TLM, and 7 patients (4%) chose RT. The most common reason for choosing TLM was shorter treatment and more treatment options in case of recurrence. Subanalysis showed that additional counseling by the radiotherapist did not seem to affect our patients’ preferences for TLM in this group. CONCLUSIONS: The majority of patients in our study prefer TLM to RT when given a choice. Reasons given indicate that optimizing future treatment options and practical considerations seemed more important to our patients than primary functional outcome. Further research is needed to study patient-related and physician-related factors to gain more insight into this complicated process of shared decision making. |
format | Online Article Text |
id | pubmed-5815424 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-58154242018-03-01 Treatment Preferences in Patients With Early Glottic Cancer van Loon, Yda Hendriksma, Martine Langeveld, Ton P.M. de Jong, Martin A. Baatenburg de Jong, Rob J. Sjögren, Elisabeth V. Ann Otol Rhinol Laryngol Articles OBJECTIVE: For early glottic carcinoma, the 2 main treatment modalities are radiotherapy (RT) and transoral CO(2) laser microsurgery (TLM). The aim of this study was to investigate treatment preferences and considerations in patients with early glottic carcinoma (T1-T2) who were given a choice between TLM and RT. SUBJECTS AND METHODS: Patients with early glottic cancer (suspected or confirmed extended T1 or limited T2) were counseled by an ENT-surgeon. A subset of 32 patients was also counseled by a radiotherapist. Treatment choice and considerations were recorded and analyzed. RESULTS: Of 175 patients, 168 patients (96%) chose TLM, and 7 patients (4%) chose RT. The most common reason for choosing TLM was shorter treatment and more treatment options in case of recurrence. Subanalysis showed that additional counseling by the radiotherapist did not seem to affect our patients’ preferences for TLM in this group. CONCLUSIONS: The majority of patients in our study prefer TLM to RT when given a choice. Reasons given indicate that optimizing future treatment options and practical considerations seemed more important to our patients than primary functional outcome. Further research is needed to study patient-related and physician-related factors to gain more insight into this complicated process of shared decision making. SAGE Publications 2017-12-31 2018-03 /pmc/articles/PMC5815424/ /pubmed/29291278 http://dx.doi.org/10.1177/0003489417749253 Text en © The Author(s) 2017 http://www.creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Articles van Loon, Yda Hendriksma, Martine Langeveld, Ton P.M. de Jong, Martin A. Baatenburg de Jong, Rob J. Sjögren, Elisabeth V. Treatment Preferences in Patients With Early Glottic Cancer |
title | Treatment Preferences in Patients With Early Glottic Cancer |
title_full | Treatment Preferences in Patients With Early Glottic Cancer |
title_fullStr | Treatment Preferences in Patients With Early Glottic Cancer |
title_full_unstemmed | Treatment Preferences in Patients With Early Glottic Cancer |
title_short | Treatment Preferences in Patients With Early Glottic Cancer |
title_sort | treatment preferences in patients with early glottic cancer |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815424/ https://www.ncbi.nlm.nih.gov/pubmed/29291278 http://dx.doi.org/10.1177/0003489417749253 |
work_keys_str_mv | AT vanloonyda treatmentpreferencesinpatientswithearlyglotticcancer AT hendriksmamartine treatmentpreferencesinpatientswithearlyglotticcancer AT langeveldtonpm treatmentpreferencesinpatientswithearlyglotticcancer AT dejongmartina treatmentpreferencesinpatientswithearlyglotticcancer AT baatenburgdejongrobj treatmentpreferencesinpatientswithearlyglotticcancer AT sjogrenelisabethv treatmentpreferencesinpatientswithearlyglotticcancer |